Intervention: Second Allogeneic Bone Marrow Transplantation
Found 126 matching trials
Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome
PHASE2
RATIONALE: Drugs used in chemotherapy, such as idarubicin and cytarabine, w...
Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant
PHASE1
RATIONALE: Biological therapies, such as cellular adoptive immunotherapy, s...
Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's Anemia
NA
OBJECTIVES:
I. Determine the effectiveness of moderate dose cyclophosphami...
Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
PHASE2
RATIONALE: Monoclonal antibodies such as gemtuzumab ozogamicin can locate c...